Search  Login Impressum Data-Privacy Contact
Logo
  • Network Services
    Management Informatics Registries
  • Leukemias
    ALL AML CML CLL MPN MDS
  • Diagnostics
    Diagnostics Cytogenetics MRD Next generation sequencing
  • Treat. Research
    SCT Supportive Care Quality of Life and Late Effects
  • Physicians
    Treatment Adverse Reactions Diagnosis Recommendations Links Dates / Meetings
  • Trials
    Structure Workshops Legislation Links
  • Press Releases
  • Links
  1. ELN
  2. Press/Media
  3. Press Releases
  4. ·

Press Releases

application/pdf 28 June 2007: Novartis / ELN Collaboration (32KB)
ELN_Press_Release280607.pdf
European Leukaemia Network is announcing long term collaboration with Novartis to improve understanding and treatment of Chronic Myeloid Leukemia

About us

The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care and cure.

Lastest Posts

Links

  • CML-Collaboration
  • Cytogenetics
  • SCT
  • Supportive Care

Kontakt-Info

ELN-Foundation
Im Langgewann 45
69469 Weinheim, Germany

Hehlmann.ELN@gmail.com

www.elnfoundation.org

© 2004-2025 ELN-Foundation - All Rights Reserved.
  • Data-Privacy
  • |
  • Impressum
  • |
  • Contact